PNC Financial Services Group
IGC icon

PNC Financial Services Group’s IGC Pharma IGC Stock Holding History

PNC Financial Services Group’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-400
Closed -$128 – 4753
2022
Q4 		$128 Buy
+400
New +$163 ﹤0.01% 4680
2015
Q2 		– Sell
-250
Closed – – 4722
2015
Q1 		$0 Buy
+250
New +$135 ﹤0.01% 4722

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

PNC Financial Services Group's IGC Position: Q1 2023 in Review

PNC Financial Services Group sold out of IGC Pharma (IGC) in Q1 2023, closing a stake of 400 shares — an estimated $128 sold.

PNC Financial Services Group first reported a position in IGC in Q1 2015 and held it in 2 quarters. The position peaked at $128 in Q4 2022. 23 funds tracked by Wall St. Rank hold IGC as of Q1 2023.

  • PNC Financial Services Group reported no remaining IGC Pharma position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 400 IGC Pharma shares in Q1 2023, an estimated $128.
  • PNC Financial Services Group first reported a position in IGC Pharma in Q1 2015 and held it in 2 quarters.
  • PNC Financial Services Group's IGC Pharma position peaked at $128 in Q4 2022.
  • 23 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.